Literature DB >> 26598951

Topical diphencyprone for the treatment of locoregional intralymphatic melanoma metastases of the skin; the 5-year Norwich experience.

M Moncrieff1, M Fadhil1, J Garioch1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26598951     DOI: 10.1111/bjd.14314

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  5 in total

Review 1.  Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata.

Authors:  Kun-Wei Lai; Tsen-Fang Tsai
Journal:  Dermatol Ther (Heidelb)       Date:  2022-09-22

Review 2.  Topical and intralesional therapies for in-transitmelanoma.

Authors:  Michael A Henderson
Journal:  Melanoma Manag       Date:  2019-09-02

3.  Diphencyprone as a therapeutic option in cutaneous metastasis of melanoma. A single-institution experience.

Authors:  Ivana Lameiras Gibbons; Marina Sonagli; Eduardo Bertolli; Mariana Petaccia de Macedo; Clovis Antonio Lopes Pinto; João Pedreira Duprat Neto
Journal:  An Bras Dermatol       Date:  2018-03       Impact factor: 1.896

4.  Protocol for the TIDAL Melanoma Study: topical imiquimod or diphenylcyclopropenone for the management of cutaneous in-transit melanoma metastases-a phase II, single centre, randomised, pilot study.

Authors:  Tavis Read; Scott Webber; Janine Thomas; Michael Wagels; Helmut Schaider; H Peter Soyer; B Mark Smithers
Journal:  BMJ Open       Date:  2017-10-06       Impact factor: 2.692

5.  Quantitative and Spatial Analysis of CD8+/PD-1 Tumor-Infiltrating Lymphocytes as a Predictive Biomarker for Clinical Response of Melanoma In-Transit Metastases to Topical Immunotherapy.

Authors:  Sophia Haywood; Jennifer Garioch; Arjun Ramaiya; Marc Moncrieff
Journal:  Ann Surg Oncol       Date:  2020-06-15       Impact factor: 5.344

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.